High levels of ACE2 expression in nasal mucosa are consistent with clinical findings indicating symptomatic COVID-19 patients have higher viral loads in their nasal cavities than in their throats, which may explain why some patients report losing their sense of smell. Here, ACE2 is linked to COVID-19.